Intuitive Surgical (NASDAQ:ISRG) CEO David Rosa Sells 24,500 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) CEO David Rosa sold 24,500 shares of the firm’s stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Intuitive Surgical Trading Up 0.9%

Shares of NASDAQ ISRG opened at $551.25 on Tuesday. The stock has a market cap of $197.61 billion, a price-to-earnings ratio of 72.92, a P/E/G ratio of 5.02 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock’s 50-day moving average is $459.49 and its 200 day moving average is $497.31.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.Intuitive Surgical’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same period last year, the firm posted $1.84 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on ISRG shares. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. HSBC raised their price target on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Wells Fargo & Company raised their price target on Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Finally, UBS Group set a $600.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $603.38.

Institutional Investors Weigh In On Intuitive Surgical

Large investors have recently made changes to their positions in the business. Aaron Wealth Advisors LLC raised its holdings in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares in the last quarter. Crown Wealth Group LLC raised its holdings in Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after purchasing an additional 20 shares in the last quarter. FSM Wealth Advisors LLC raised its holdings in Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after purchasing an additional 20 shares in the last quarter. CFO4Life Group LLC raised its holdings in Intuitive Surgical by 4.8% during the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after purchasing an additional 20 shares in the last quarter. Finally, J. W. Coons Advisors LLC raised its holdings in Intuitive Surgical by 1.4% during the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after purchasing an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.